CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

European Journal of Cancer

Volumn 60, Issue , 2016, Pages 1-11

  Workel, Hagma H ^a   Komdeur, Fenne L ^a   Wouters, Maartje C A ^a   Plat, Annechien ^a   Klip, Harry G ^a   Eggink, Florine A ^a   Wisman, G Bea A ^a   Arts, Henriette J G ^a   Oonk, Maaike H M ^a   Mourits, Marian J E ^a   Yigit, Refika ^a   Versluis, Marco ^a   Duiker, Evelien W ^a   Hollema, Harry ^a   De Bruyn, Marco ^a   Nijman, Hans W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adenocarcinoma; CD103; Endometrial cancer; Survival; Tumour infiltrating lymphocytes

Indexed keywords

ALPHA E BETA7 INTEGRIN; ANTINEOPLASTIC AGENT; BETA7 INTEGRIN; CD103 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; PD1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR PROTEIN; UNCLASSIFIED DRUG; ALPHA E INTEGRINS; ALPHA INTEGRIN; INTEGRIN; INTEGRIN ALPHA4BETA7; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CELL INFILTRATION; COHORT ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; ADENOCARCINOMA; AGED; CD8+ T LYMPHOCYTE; ENDOMETRIAL NEOPLASMS; IMMUNOLOGY; METABOLISM; PHENOTYPE; PROGNOSIS; T LYMPHOCYTE SUBPOPULATION;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRINS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PHENOTYPE; PROGNOSIS; T-LYMPHOCYTE SUBSETS;

EID: 84961918720     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.02.026     Document Type: Article

References (19)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 Mar-Apr 69 90
2. N. Colombo, E. Preti, F. Landoni, S. Carinelli, A. Colombo, C. Marini, and et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 Suppl. 6 2013 vi33 vi38
3. S. Kondratiev, E. Sabo, E. Yakirevich, O. Lavie, and M.B. Resnick Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma Clin Cancer Res 10 13 2004 4450 4456
4. R.A. de Jong, N. Leffers, H.M. Boezen, K.A. ten Hoor, A.G. van der Zee, H. Hollema, and et al. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer Gynecol Oncol 114 1 2009 105 110
5. W.C. Chang, C.H. Li, S.C. Huang, D.Y. Chang, L.Y. Chou, and B.C. Sheu Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma Cancer 116 24 2010 5777 5788
6. P.I. Karecla, S.J. Green, S.J. Bowden, J. Coadwell, and P.J. Kilshaw Identification of a binding site for integrin alphaEbeta7 in the N-terminal domain of E-cadherin J Biol Chem 271 48 1996 30909 30915
7. K.L. Cepek, S.K. Shaw, C.M. Parker, G.J. Russell, J.S. Morrow, D.L. Rimm, and et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin Nature 372 6502 1994 190 193
8. A. Le Floc'h, A. Jalil, I. Vergnon, B. Le Maux Chansac, V. Lazar, G. Bismuth, and et al. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis J Exp Med 204 3 2007 559 570
9. K.L. Cepek, C.M. Parker, J.L. Madara, and M.B. Brenner Integrin alpha E beta 7 mediates adhesion of T lymphocytes to epithelial cells J Immunol 150 8 Pt 1 1993 3459 3470
10. K. Franciszkiewicz, A. Le Floc'h, A. Jalil, F. Vigant, T. Robert, I. Vergnon, and et al. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention Cancer Res 69 15 2009 6249 6255
11. A. Le Floc'h, A. Jalil, K. Franciszkiewicz, P. Validire, I. Vergnon, and F. Mami-Chouaib Minimal engagement of CD103 on cytotoxic T lymphocytes with an E-cadherin-Fc molecule triggers lytic granule polarization via a phospholipase Cgamma-dependent pathway Cancer Res 71 2 2011 328 338
12. K. Franciszkiewicz, A. Le Floc'h, M. Boutet, I. Vergnon, A. Schmitt, and F. Mami-Chouaib CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions Cancer Res 73 2 2013 617 628
13. F. Djenidi, J. Adam, A. Goubar, A. Durgeau, G. Meurice, V. de Montpreville, and et al. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T Cells and a prognostic factor for survival in lung cancer patients J Immunol 194 7 2015 3475 3486
14. J.R. Webb, K. Milne, P. Watson, R.J. Deleeuw, and B.H. Nelson Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer Clin Cancer Res 20 2 2014 434 444
15. B. Wang, W. Shaoxu, H. Zeng, Z. Liu, W. Dong, H. Wang, and et al. CD103 tumor-infiltrating lymphocytes predict a favorable prognosis in urothelial cell carcinoma of the bladder J Urol 2015
16. J.R. Webb, D.A. Wick, J.S. Nielsen, E. Tran, K. Milne, E. McMurtrie, and et al. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer Gynecol Oncol 118 3 2010 Sep 228 236
17. J.R. Webb, K. Milne, and B.H. Nelson PD-1 and CD103 are widely co-expressed on prognostically favorable intraepithelial CD8 T cells in human ovarian cancer Cancer Immunol Res 2015
18. I.C. van Gool, F.A. Eggink, L. Freeman-Mills, E. Stelloo, E. Marchi, M. de Bruyn, and et al. POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer Clin Cancer Res 2015
19. S.A. Rosenberg, J.C. Yang, R.M. Sherry, U.S. Kammula, M.S. Hughes, G.Q. Phan, and et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy Clin Cancer Res 17 13 2011 4550 4557